OFS
EW icon

Orrstown Financial Services’s Edwards Lifesciences EW Stock Holding History

Orrstown Financial Services’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-390
Closed -$10K – 214
2015
Q4 		$10K Hold
390
– – 0.01% 156
2015
Q3 		$9K Buy
+390
New +$9.41K 0.01% 172

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Orrstown Financial Services's EW Position: Q1 2016 in Review

Orrstown Financial Services sold out of Edwards Lifesciences (EW) in Q1 2016, closing a stake of 390 shares — an estimated $10K sold.

Orrstown Financial Services first reported a position in EW in Q3 2015 and held it in 2 quarters. The position peaked at $10K in Q4 2015. 659 funds tracked by Wall St. Rank hold EW as of Q1 2016.

  • Orrstown Financial Services reported no remaining Edwards Lifesciences position as of Q1 2016 after selling out during the quarter.
  • Orrstown Financial Services sold 390 Edwards Lifesciences shares in Q1 2016, an estimated $10K.
  • Orrstown Financial Services first reported a position in Edwards Lifesciences in Q3 2015 and held it in 2 quarters.
  • Orrstown Financial Services's Edwards Lifesciences position peaked at $10K in Q4 2015.
  • 659 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2016.

Based on Orrstown Financial Services's 13F filing for Q1 2016, filed 8 Apr 2016.